Apellis Pharmaceuticals, Inc. (APLS) — Business segments and KPIs
Revenue by business segment and geography for Apellis Pharmaceuticals, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Product | 689.38M | 68.7% |
| Licensing And Other Revenue | 314.4M | 31.3% |